Using the industry peer median EV/Revenue multiple (trailing + forward), Synergy CHC Corp. (SNYR) has a fair value of $94.05 based on 6 comparable companies in the Medical - Distribution industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Synergy CHC Corp.SNYR | 4 | 0.9x | 0.8x |
| Rallybio Corporation | 78 | 54.0x | 66.2x |
| Allarity Therapeutics, Inc. | 25 | 35.1x | 0.2x |
| Adagio Medical Holdings, Inc. | 15 | 39.1x | 4.3x |
| Envoy Medical, Inc. | 13 | 44.0x | 53.0x |
| Nexalin Technology, Inc. | 7 | 21.9x | 38.4x |
| ProPhase Labs, Inc. | 1 | 3.6x | 0.2x |
| Industry Median | 37.1x | 21.4x | |
| (*) Revenue | 30 | 35 | |
| = Enterprise Value | 1,127 | 750 | |
| (-) Net Debt | 24 | 24 | |
| Equity Value | 1,103 | 726 | |
| (/) Outstanding shares | 10 | 10 | |
| Fair Price | $113 | $75 | |
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.